These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15298021)

  • 1. India expands mass chemotherapy to eradicate filariasis.
    Sharma DC
    Lancet Infect Dis; 2004 Aug; 4(8):478. PubMed ID: 15298021
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
    Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
    Sunish IP; Rajendran R; Mani TR; Dash AP; Tyagi BK
    Lancet Infect Dis; 2006 Mar; 6(3):125-6. PubMed ID: 16500593
    [No Abstract]   [Full Text] [Related]  

  • 4. Mass DEC campaign for filariasis in a hyper endemic district of West Bengal.
    Haldar A; Mundle M; Haldar S; Biswas AK; Mitra SP; Mahapatra BS
    J Commun Dis; 2001 Sep; 33(3):192-7. PubMed ID: 12206039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
    Ramzy RM; El Setouhy M; Helmy H; Ahmed ES; Abd Elaziz KM; Farid HA; Shannon WD; Weil GJ
    Lancet; 2006 Mar; 367(9515):992-9. PubMed ID: 16564361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New goals set for filariasis elimination in India.
    Sharma DC
    Lancet Infect Dis; 2002 Jul; 2(7):389. PubMed ID: 12127343
    [No Abstract]   [Full Text] [Related]  

  • 7. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May; 78(20):171-9. PubMed ID: 12808788
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of albendazole-ivermectin combination and other filaricidal drugs against infective larvae, preadult, microfilariae and adult worms of Molinema dessetae in the rodent Proechimys oris.
    Duarte Z; Gantier JC; Gayral P
    Parasite; 1994 Mar; 1(1):57-64. PubMed ID: 9140472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on coverage and compliance of mass drug administration programme for elimination of filariasis in Udupi district, Karnataka, India.
    Kumar A; Kumar P; Nagaraj K; Nayak D; Ashok L; Ashok K
    J Vector Borne Dis; 2009 Sep; 46(3):237-40. PubMed ID: 19724089
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
    Khan AM
    Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
    [No Abstract]   [Full Text] [Related]  

  • 12. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
    Ranganath BG
    J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in research on filariasis. Chemotherapy.
    Goodwin LG
    Trans R Soc Trop Med Hyg; 1984; 78 Suppl():1-8. PubMed ID: 6382706
    [No Abstract]   [Full Text] [Related]  

  • 14. Sustainability of soil-transmitted helminth control following a single-dose co-administration of albendazole and diethylcarbamazine.
    Rajendran R; Mani TR; Munirathinam A; Sunish IP; Abdullah SM; Augustin DJ; Satyanarayana K
    Trans R Soc Trop Med Hyg; 2003; 97(3):355-9. PubMed ID: 15228259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
    Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
    Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of co-administration of albendazole and diethylcarbamazine against geohelminthiases: a study from South India.
    Mani TR; Rajendran R; Munirathinam A; Sunish IP; Md Abdullah S; Augustin DJ; Satyanarayana K
    Trop Med Int Health; 2002 Jun; 7(6):541-8. PubMed ID: 12031078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of lymphatic filariasis.
    Michael E; Malecela-Lazaro MN; Kazura JW
    Lancet; 2006 Jul; 368(9533):362-3; author reply 363-4. PubMed ID: 16876654
    [No Abstract]   [Full Text] [Related]  

  • 18. Coverage and compliance to diethylcarbamazine in relation to Filaria Prevention Assistants in rural Puducherry, India.
    Mahalakshmy T; Kalaiselvan G; Parmar J; Dongre A
    J Vector Borne Dis; 2010 Jun; 47(2):113-5. PubMed ID: 20539050
    [No Abstract]   [Full Text] [Related]  

  • 19. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
    Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
    Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of albendazole in programmes to eliminate lymphatic filariasis.
    Ottesen EA; Ismail MM; Horton J
    Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.